Abstract
Background
We investigated the effect of combining indomethacin and desmopressin in treating children with monosymptomatic nocturnal enuresis (MNE) and desmopressin-resistant nocturnal polyuria.
Methods
Twenty-three children with MNE, nocturnal polyuria, and partial or no response to desmopressin were recruited from incontinence clinics of our tertiary referral center. We used a randomized single-arm crossover placebo-controlled study design consisting of two 3-week treatment periods with a combination of desmopressin (0.4 mg) and indomethacin (50 mg) or desmopressin and placebo at bedtime. Home recordings at baseline and for the final 2 weeks of each treatment period were performed and included nocturnal urine output measurements. The number of dry nights achieved and reduction in the nocturnal urine output were the main effect parameters. Student’s t test and Pearson’s correlation coefficient were used for statistical analysis.
Results
The addition of indomethacin to desmopressin significantly reduced nocturnal urine output (from 324 ± 14 ml to 258 ± 13 ml, p < 0.001). This did not lead to more dry nights in all children, and we found no statistically significant reduction in enuresis frequency (from 68 % ± 0.1 to 56 % ± 0.1, p = 0.24).
Conclusions
Addition of indomethacin to desmopressin can further reduce nocturnal urine output in children with MNE and desmopressin-resistant nocturnal polyuria. The combination treatment does not, however, improve outcome in terms of frequency of nights with enuresis. The dissociation of antidiuretic and antienuretic effect may reflect nocturnal bladder reservoir dysfunction in children who present with normal daytime bladder function.
Similar content being viewed by others
References
Rittig S, Knudsen UB, Norgaard JP, Pedersen EB, Djurhuus JC (1989) Abnormal diurnal rhythm of plasma vasopressin and urinary output in patients with enuresis. Am J Physiol 256:F664–F671
Aikawa T, Kasahara T, Uchiyama M (1998) The arginine-vasopressin secretion profile of children with primary nocturnal enuresis. Eur Urol 33(Suppl 3):41–4–41–44
Glazener CM, Evans JH (2000) Desmopressin for nocturnal enuresis in children. Cochrane Database Syst Rev 3, CD002112
Yeung CK, Chiu HN, Sit FK (1999) Bladder dysfunction in children with refractory monosymptomatic primary nocturnal enuresis. J Urol 162:1049–1054
De Guchtenaere A, Raes A, Vande Walle C, Hoebeke P, Van Laecke E, Donckerwolcke R, Vande Walle J (2009) Evidence of partial anti-enuretic response related to poor pharmacodynamic effects of desmopressin nasal spray. J Urol 181:302–309, discussion 309
Rittig S, Knudsen UB, Norgaard JP, Gregersen H, Pedersen EB, Djurhuus JC (1991) Diurnal variation of plasma atrial natriuretic peptide in normals and patients with enuresis nocturna. Scand J Clin Lab Invest 51:209–217
Vurgun N, Yiditodlu MR, Ypcan A, Ari Z, Tarhan S, Balkan C (1998) Hypernatriuria and kaliuresis in enuretic children and the diurnal variation. J Urol 159:1333–1337
Aceto G, Penza R, Coccioli MS, Palumbo F, Cresta L, Cimador M, Chiozza ML, Caione P (2003) Enuresis subtypes based on nocturnal hypercalciuria: a multicenter study. J Urol 170:1670–1673
Kamperis K, Rittig S, Jorgensen KA, Djurhuus JC (2006) Nocturnal polyuria in monosymptomatic nocturnal enuresis refractory to desmopressin treatment. Am J Physiol Renal Physiol 291:F1232–1240
Rittig S, Matthiesen TB, Pedersen EB, Djurhuus JC (1999) Sodium regulating hormones in enuresis. Scand J Urol Nephrol Suppl 202:45–46
De Guchtenaere A, Vande Walle C, Van Sintjan P, Raes A, Donckerwolcke R, Van Laecke E, Hoebeke P, Vande Walle J (2007) Nocturnal polyuria is related to absent circadian rhythm of glomerular filtration rate. J Urol 178:2626–2629
Kovacevic L, Lu H, Wolfe-Christensen C, Abdulhamid I, Thottam PJ, Lulgjuraj M, Madgy DN, Lakshmanan Y (2015) Adenotonsillectomy normalizes hormones and urinary electrolytes in children with nocturnal enuresis and sleep-disordered breathing. Urology 86:158–161
Dhondt K, Raes A, Hoebeke P, Van Laecke E, Van Herzeele C, Vande Walle J (2009) Abnormal sleep architecture and refractory nocturnal enuresis. J Urol 182:1961–1965
Littlewood JM, Lee MR, Meadow SR (1976) Treatment of childhood Bartter’s syndrome with indomethacin. Lancet 2:795
Natochin YV, Kuznetsova AA (2000) Nocturnal enuresis: correction of renal function by desmopressin and diclofenac. Pediatr Nephrol 14:42–47
Sener F, Hasanoglu E, Soylemezoglu O (1998) Desmopressin versus indomethacin treatment in primary nocturnal enuresis and the role of prostaglandins. Urology 52:878–881
Varan B, Saatci U, Ozen S, Bakkaloglu A, Besbas N (1996) Efficacy of oxybutynin, pseudoephedrine and indomethacin in the treatment of primary nocturnal enuresis. Turk J Pediatr 38:155–159
Al Waili NS (1989) Indomethacin suppository to treat primary nocturnal enuresis: double- blind study. J Urol 142:1290–1292
Medel R, Dieguez S, Brindo M, Ayuso S, Canepa C, Ruarte A, Podesta ML (1998) Monosymptomatic primary enuresis: differences between patients responding or not responding to oral desmopressin. Br J Urol 81(Suppl 3):46–49
Hansen MN, Rittig S, Siggaard C, Kamperis K, Hvistendahl G, Schaumburg HL, Schmidt F, Rawashdeh Y, Djurhuus JC (2001) Intra-individual variability in nighttime urine production and functional bladder capacity estimated by home recordings in patients with nocturnal enuresis. J Urol 166:2452–2455
Raes A, Dehoorne J, Van Laecke E, Hoebeke P, Vande Walle C, Vansintjan P, Donckerwolcke R, Vande Walle J (2007) Partial response to intranasal desmopressin in children with monosymptomatic nocturnal enuresis is related to persistent nocturnal polyuria on wet nights. J Urol 178:1048–1051, discussion 1051-1042
Vande Walle J, Vande Walle C, Van Sintjan P, De Guchtenaere A, Raes A, Donckerwolcke R, Van Laecke E, Mauel R, Dehoorne J, Van Hoyweghen E, Hoebeke P (2007) Nocturnal polyuria is related to 24-hour diuresis and osmotic excretion in an enuresis population referred to a tertiary center. J Urol 178:2630–2634
Kuznetsova AA, Shakhmatova EI, Prutskova NP, Natochin YV (2000) Possible role of prostaglandins in pathogenesis of nocturnal enuresis in children. Scand J Urol Nephrol 34:27–31
Al Waili NS (2002) Increased urinary nitrite excretion in primary enuresis: effects of indomethacin treatment on urinary and serum osmolality and electrolytes, urinary volumes and nitrite excretion. BJU Int 90:294–301
Batislam E, Nuhoglu B, Peskircioglu L, Emir L, Uygur C, Germiyanoglu C, Erol D (1995) A prostaglandin synthesis inhibitor, diclofenac sodium in the treatment of primary nocturnal enuresis. Acta Urol Belg 63:35–38
Gelotte CK, Prior MJ, Gu J (2009) A randomized, placebo-controlled, exploratory trial of Ibuprofen and pseudoephedrine in the treatment of primary nocturnal enuresis in children. Clin Pediatr (Phila) 48:410–419
Rahnama’i MS, van Kerrebroeck PE, de Wachter SG, van Koeveringe GA (2012) The role of prostanoids in urinary bladder physiology. Nat Rev Urol 9:283–290
Angelico P, Guarneri L, Velasco C, Cova R, Leonardi A, Clarke DE, Testa R (2006) Effect of cyclooxygenase inhibitors on the micturition reflex in rats: correlation with inhibition of cyclooxygenase isozymes. BJU Int 97:837–846
Fine LG, Trizna W (1977) Influence of prostaglandins on sodium transport of isolated medullary nephron segments. Am J Physiol 232:F383–F390
Sakairi Y, Jacobson HR, Noland TD, Breyer MD (1995) Luminal prostaglandin E receptors regulate salt and water transport in rabbit cortical collecting duct. Am J Physiol 269:F257–F265
Kamperis K, Rittig S, Bower WF, Djurhuus JC (2012) Effect of indomethacin on desmopressin resistant nocturnal polyuria and nocturnal enuresis. J Urol 188:1915–1922
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Financial statement
The study was financially supported by Karen Elise Jensen Foundation.
Conflict of interest
All authors declare that they have no conflicting interests involving this work.
Ethics statement
The study protocol was approved by the local Ethics Committee and informed consent was acquired from all participants and their parents. The protocol conformed to the recommendations for good clinical practice (CPMP/ICH/135/95) and was registered with clinicaltrials.gov (NCT00226122).
Rights and permissions
About this article
Cite this article
Kamperis, K., Hagstroem, S., Faerch, M. et al. Combination treatment of nocturnal enuresis with desmopressin and indomethacin. Pediatr Nephrol 32, 627–633 (2017). https://doi.org/10.1007/s00467-016-3536-9
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00467-016-3536-9